Issue link: https://htpgraphics.uberflip.com/i/768723
University of Manchester spin-out, MicroBiosensor Ltd, won the Bionow Healthcare Project of the Year Award for their InfectDetect project. The company, which spun-out of the Medical Device Biology Group in the Division of Pharmacy and Optometry, has devised and manufactured a prototype simple novel antimicrobial susceptibility diagnostic to prevent hospital admission due to urinary tract infection. The new project, led by Dr Nishal-Govindji-Bhatt and Dr Duncan Henderson, should provide appreciable savings to the NHS, impact the rise of antimicrobial resistance, as well as reduce suffering in vulnerable clinical populations. The award was sponsored by TRUSTECH. Professor Curtis Dobson, Chairman and Founder of MicroBiosensor, comments: "It was fantastic news for Microbiosensor to win this Award, which recognises the dramatic progress we have made this year in developing a second product featuring our exciting proprietary technology. Microbiosensor now has two high quality products nearing a CE Mark, and these are poised to have a major global impact, both delivering significant savings for the healthcare providers and improving patient outcomes." University of Manchester Research Fellow Dr Bianca Price (who is also based in the Medical Device Biology Group) won the Bionow Promising Technologist of the Year Award for her work in creating an innovative 'infected wound in a dish'. The model has evaluated anti-infective products from different industrial collaborators, including a novel wound filler and antimicrobial dressings. The award was sponsored by Seqirus. Dr Price comments: "It is wonderful to be acknowledged for innovative work that has real world impact in this way. The model developed in the Medical Device Biology Group has generated lots of interest in the wound care sector as a relevant way to test movement and efficacy of antimicrobials released from medical devices. We will continue to develop and apply this model as well as other complimentary approaches over the coming years." Congratulations also go to colleagues at the Greater Manchester Academic Health Science Network for winning the Bionow Business Services Award, sponsored by Skills and Growth Company. To cap the night off, University spin-out, F2G Ltd, won the Bionow Investment Deal of the Year Award for their $60M financing round. F2G is an established Manchester-based specialist antifungal company developing a completely new class of antifungal agents to treat life threatening invasive fungal infections. The award was sponsored by QIAGEN Manchester. For more information about Bionow, please visit www.bionow.co.uk The Bionow Awards Dinner was sponsored by Manchester Science Partnerships, Appleyard Lees, CY Partners, Redx Pharma and World Courier.